News | News By Subject | News by Disease News By Date | Search News

Atrial Fibrillation News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Boehringer Ingelheim Corporation's Investigational Antidote For Pradaxa® Grabs FDA Breakthrough Therapy Designation     6/26/2014
Bristol-Myers Squibb Company (BMY)'s Eliquis® Works As Well As Pfizer Inc. (PFE)'s In Head-To-Head Subanalysis Study     3/27/2014
Servier, Xention Limited Sign Potential $163.2 Million Deal to Develop AF Drug     10/3/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey     9/25/2013
Cardiome Pharma Corp. (COM.TO) Announces Publication of Positive Data From a Study Comparing Vernakalant IV Versus Propafenone and Flecainide     9/23/2013
ARCA biopharma, Medtronic, Inc. (MDT) Collaborate on Atrial Fibrillation Trial     4/22/2013
Bristol-Myers Squibb (BMY)-Pfizer (PFE)'s Blood Thinner Eliquis Wins FDA Approval     1/3/2013
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal     11/28/2012
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE) Anticlot Drug Gets Key EU Approval     11/23/2012
Boehringer Ingelheim Corporation Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa®     11/7/2012
FDA Issues Import Alerts for 22 Chinese Heparin Suppliers     2/24/2012
Bayer HealthCare (BAY)'s Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in Non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis     12/19/2011

News from Around the Web
Booze Daily May Boost Atrial Fibrillation Risk, AHA Study     9/15/2016
Device That Reduces Risk Of Atrial Fibrillation Being Used In Colorado, University Of Colorado Hospital Reveals     3/24/2016
Losing Weight Can Keep Irregular Heartbeat In Check, Intermountain Medical Center Heart Institute Research Finds     11/9/2015
More Evidence Proves Coffee Doesn't Harm Your Heart, Karolinska Institute Study     9/23/2015
Botox May Erase Irregular Heartbeat Issues, State Research Institute Of Circulation Pathology Reveals     5/15/2015
200-Year-Old Heart Drug Linked To Premature Death, European Hearth Journal Reveals     5/7/2015
Fish Oil Supplements Have Little Effect On Irregular Heartbeat, Montreal Heart Institute Study     10/17/2014
Moderate Alcohol Use Associated With Increased Risk For Atrial Fibrillation, Karolinska Institute Study     7/24/2014
New Targeting Technology Improves Outcomes for Patients With Atrial Fibrillation, University of California, Los Angeles (UCLA), University of California, San Diego (UCSD), Indiana University Study     7/19/2012
New Agent Prevents Stroke in Patients With Atrial Fibrillation, Duke Clinical Research Institute Study Suggests     8/11/2011
Study Shows Epleronone to Reduce Atrial Fibrillation, University of Gothenburg Study     5/23/2011
Statins Don't Suppress Afib After Ablation, Mayo Clinic Study Finds     5/9/2011
Biomarker May Predict Adverse Events in Atrial Fibrillation, University of Birmingham Study     4/15/2011
Oxidative Stress May Help Predict Atrial Fibrillation Risk, Emory University School of Medicine Study     4/8/2011
Yoga Stretches Afib Attack Frequency, University of Kansas Study     4/4/2011

Press Releases
New Research Confirms Significance Of AliveCor's 30 Second EKG     9/6/2017
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Alliance Announce Real-World Observational Analysis Of The Effectiveness And Safety Of Direct Oral Anticoagulants Compared To Warfarin In Elderly Patients With Non-Valvular Atrial Fibrillation     8/29/2017
Boehringer Ingelheim Release: Pradaxa (Dabigatran Etexilate) Dual Therapy Showed Lower Rates Of Major Bleeding Versus Triple Therapy With Warfarin In Atrial Fibrillation Patients Undergoing Stent Placement     8/28/2017
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Present Observational Real-World Data Analysis On The Effectiveness And Safety Of Eliquis (Apixaban) Compared To Warfarin In Select High-Risk Patients With Non-Valvular Atrial Fibrillation     8/28/2017
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Present Investigational Eliquis (Apixaban) Data For Patients With Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion     8/28/2017
Bristol-Myers Squibb (BMY) And Pfizer (PFE) To Highlight Commitment To Reducing The Risk Of Stroke Caused By Non-Valvular Atrial Fibrillation (NVAF) And Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) At ESC Congress 2017     8/18/2017
ARCA biopharma Announces Completion Of Enrollment For GENETIC-AF Phase IIb Clinical Trial     8/16/2017
Clinical Trial To Evaluate Medtronic (MDT) Cryoablation As First-Line Treatment For Patients With Symptomatic Paroxysmal Atrial Fibrillation     7/11/2017
CardioFocus Announces Initiation Of Three Major Studies Featuring The HeartLight System For The Treatment Of Atrial Fibrillation     6/29/2017
New Expert Statement Recognizes Patch Monitors Such As Zio By iRhythm As Effective For Atrial Fibrillation Monitoring Post-Ablation     6/21/2017
Medtronic (MDT) Exclusive Reactive ATP Therapy Slows Progression Of Atrial Fibrillation In Real-World Patient Population     6/19/2017
Cardiome Pharma Corp. (COM.TO) Announces Commercial Launch Of BRINAVESS (Vernakalant Hydrochloride) In Canada     6/12/2017
InCarda Announces Positive Clinical Data Supporting Development Of Inhaled Flecainide For The Treatment Of Symptomatic Acute Events Of Paroxysmal Atrial Fibrillation (PAF)     6/7/2017
New Study Shows Medtronic (MDT) Insertable Cardiac Monitors Detect High Rate Of Atrial Fibrillation In Previously Undiagnosed High-Risk Patients     5/15/2017
Heart Rhythm Society Release: New Study Shows Delayed Use Of Blood Thinners For Atrial Fibrillation Increases Risk Of Dementia     5/12/2017

//-->